Suppr超能文献

印度再治疗结核病患者治疗中断的危险因素,2006 年。

Risk factors for treatment default among re-treatment tuberculosis patients in India, 2006.

机构信息

Central Tuberculosis Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, New Delhi, India.

出版信息

PLoS One. 2010 Jan 25;5(1):e8873. doi: 10.1371/journal.pone.0008873.

Abstract

SETTING

Under India's Revised National Tuberculosis Control Programme (RNTCP), >15% of previously-treated patients in the reported 2006 patient cohort defaulted from anti-tuberculosis treatment.

OBJECTIVE

To assess the timing, characteristics, and risk factors for default amongst re-treatment TB patients.

METHODOLOGY

For this case-control study, in 90 randomly-selected programme units treatment records were abstracted from all 2006 defaulters from the RNTCP re-treatment regimen (cases), with one consecutively-selected non-defaulter per case. Patients who interrupted anti-tuberculosis treatment for >2 months were classified as defaulters.

RESULTS

1,141 defaulters and 1,189 non-defaulters were included. The median duration of treatment prior to default was 81 days (25%-75% interquartile range 44-117 days) and documented retrieval efforts after treatment interruption were inadequate. Defaulters were more likely to have been male (adjusted odds ratio [aOR] 1.4, 95% confidence interval [CI] 1.2-1.7), have previously defaulted anti-tuberculosis treatment (aOR 1.3 95%CI 1.1-1.6], have previous treatment from non-RNTCP providers (AOR 1.3, 95%CI 1.0-1.6], or have public health facility-based treatment observation (aOR 1.3, 95%CI 1.1-1.6).

CONCLUSIONS

Amongst the large number of re-treatment patients in India, default occurs early and often. Improved pre-treatment counseling and community-based treatment provision may reduce default rates. Efforts to retrieve treatment interrupters prior to default require strengthening.

摘要

背景

根据印度修订后的国家结核病控制规划(RNTCP),在报告的 2006 年患者队列中,超过 15%的既往治疗患者从抗结核治疗中退出。

目的

评估再治疗结核病患者中退出治疗的时间、特征和危险因素。

方法

在这项病例对照研究中,从 RNTCP 再治疗方案中随机选择了 90 个方案单位的治疗记录,从每个病例中选择了一个连续选择的非退出者,对所有 2006 年的退出者(病例)进行了分析。将中断抗结核治疗超过 2 个月的患者分类为退出者。

结果

共纳入了 1141 名退出者和 1189 名非退出者。在退出前,治疗的中位数持续时间为 81 天(25%-75%四分位间距为 44-117 天),且中断治疗后的检索工作不充分。退出者更有可能为男性(调整后的优势比[aOR]1.4,95%置信区间[CI]1.2-1.7),以前曾因结核病治疗而退出(aOR 1.3,95%CI 1.1-1.6),以前曾接受非 RNTCP 提供者的治疗(AOR 1.3,95%CI 1.0-1.6),或接受基于公共卫生机构的治疗观察(aOR 1.3,95%CI 1.1-1.6)。

结论

在印度大量的再治疗患者中,退出治疗的情况发生得早且经常。改进治疗前咨询和基于社区的治疗提供可能会降低退出率。需要加强在退出前检索中断治疗者的努力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b1c/2810342/72f60c4ec5ec/pone.0008873.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验